Orthobiologics Market Share, Size, Trends, Industry Analysis Report, By End-Use (Hospitals, Orthopedic Clinics, Ambulatory Care Centers, Research & Academic Institutes, Others); By Product; By Application; By Region; Segment Forecast, 2022 - 2030
The global orthobiologics market size is expected to reach USD 11.77 billion by 2030, according to a new study by Polaris Market Research. The report “Orthobiologics Market Share, Size, Trends, Industry Analysis Report, By Product (Demineralized Bone Matrix(DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy, and Others); By Application; By End-Use; By Region; Segment Forecast, 2022 – 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increased use of platelet-rich plasma, homologous conditioned plasma, and adipose-generated stromal cell treatment is also predicted to contribute to market expansion. Orthobiologics, which are most usually connected with sports injuries, are organic substances, including platelet-rich plasma (PRP) or stem cells, that are used to accelerate the recovery process for musculoskeletal problems.
They can be used alone as well as in conjunction with traditional pharmacological and non-pharmaceutical therapy options. Orthobiologic therapies, in particular, consider introducing large concentrations of natural sources of cellular ingredients to an injury site to accelerate the recovery process of muscles, ligaments, soft tissue, joints, and other organs, thereby reducing recovery time and due to injuries pain, and swelling.
Further, the development in the occurrence of sports injuries and road accidents is likely to drive the growth of the market during the forecast period. As per the John Hopkins Medicines, in the United States, about 30 million children and teenagers participate in some type of sports, and every year, around 3.5 million injuries occur, which results in some loss of engagement time.
Thus, orthobiologic therapies are utilized in sports medicine to treat either acute or chronic disorders, including typical overuse injuries. Athletes and orthopedists frequently turn to orthobiologic therapy to quickly recover an athlete to the pre-injury physical state. Most orthopedists will try to employ biologics instead of medications and/or intrusive surgery.
Furthermore, the rise in the prevalence of spinal illnesses and disorders is expected to fuel the expansion of the market. For instance, as per the National Spinal Cord Injury Statistical Center, the average annual incidence of SCI is around 54 instances per one million individuals, or approximately 17,810 additional SCI cases each year.
As per the WHO, every year, approximately 250 000 and 500 000 people worldwide develop a spinal cord injury (SCI). Most spinal cord accidents are caused by avoidable causes such as car accidents and falls. Therefore, the rising prevalence of sports injuries along with spinal disorders are the factors that are boosting the demand for orthobiologics therapy or treatment and are driving the market growth.
Orthobiologics Market Report Highlights
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook